drugset / Trial / NCT07412535

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

NCT07412535 ↗

Completed 34 enrolled Mansoura University
RandomizedParallel-groupOpen-labelTreatment

Summary

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Timeline

Start
2024-03-01
Primary completion
2024-10-01
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject E-PEF Unknown — —
Subject Sodium Hyaluronate Other / unclassified — —
Background bovine bone Unknown — —

Indications

No indication recorded.